Non-Contributory Plan Eligibility Period

A non-contributory plan eligibility period is a waiting period that employees must satisfy before becoming eligible for coverage under a non-contributory insurance plan. During this period, employees do not contribute any premiums towards the insurance policy.

Here are some key features of a non-contributory plan eligibility period:

• Waiting period: A non-contributory plan eligibility period is a waiting period before an employee can enroll in a non-contributory insurance plan.

• Length of eligibility period: The length of the eligibility period can vary depending on the policy and the employer's preferences. Common periods are 30, 60, or 90 days.

• Employee eligibility: The eligibility period applies to new employees and may also apply to existing employees who were previously ineligible for the plan.

• Plan benefits: While employees are waiting to become eligible, they may not receive any plan benefits, including coverage for medical expenses or other insurance benefits.

• Pre-existing conditions: If an employee has a pre-existing medical condition, the condition may not be covered during the eligibility period.

Example: A company offers a non-contributory group health insurance policy to its employees. The policy has a 90-day eligibility period for new hires. During the eligibility period, employees do not contribute any premiums, and they are not eligible for any plan benefits. Once the 90-day eligibility period has passed, eligible employees can enroll in the policy and receive full coverage.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.